ZYGO Series—PHARMACEUTICAL ACCESS: Global Drug Management and Underserved Populations
October 24, 2014, DML 241 | 12:30 PM - 1:30 PM | Lunch Provided
Co-sponsored by the USC Sidney Harman Academy for Polymathic Study
The pharmaceutical industry is frequently criticized as being focused entirely on making a profit and not truly caring for the wellbeing of the people. This seminar will explore if pharmaceutical companies have any ethical obligations towards underserved populations, or if, like any other company, ultimately serve to gain profit.
The Agreement of Trade-Related Aspects of Intellectual Property Rights was passed by the World Trade Organization in 1996, enabling countries without access to patented pharmaceuticals to apply for compulsory licenses and produce generic copies of drugs without the permission of the patent owner. Since 2003, compulsory license holders can also export generic drugs to other countries that lack production capabilities. Panelists will
consider how compulsory licenses both improve and complicate the landscape of pharmaceutical access on a global scale. More
Moderator: Sucharita Yellapragada, ZYGO Student Program Manager
Jeff McCombs, Associate Professor and Director of Graduate Studies, Clinical Pharmacy and Pharmaceutical Economics & Policy, USC Schaeffer
Erin Quinn, Associate Dean for Science and Health, USC Dornsife
Heather Wipfli, Associate Director, USC Institute for Global Health and Assistant Professor, Department of Preventative Medicine and School of International Relations, USC Keck
Harleen Marwah, Graduate Student, Global Medicine, USC Keck
The ZYGO Series is organized by USC students in health and medicine who seek dialogue with USC faculty across disciplines in order to increase the integration of ethical themes into their curriculum.
zygo / ˈzʌɪgəʊ, ˈzɪgəʊ / pref. relating to union or joining